Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.63B | 15.06B | 14.16B | 14.61B | 12.41B | 11.84B |
Gross Profit | 3.92B | 4.01B | 3.68B | 3.79B | 3.10B | 3.13B |
EBITDA | 1.85B | 2.13B | 1.98B | 1.97B | 1.43B | 1.63B |
Net Income | 1.13B | 1.22B | 1.05B | 1.07B | 680.08M | 857.84M |
Balance Sheet | ||||||
Total Assets | 20.80B | 21.34B | 20.38B | 19.77B | 18.14B | 17.21B |
Cash, Cash Equivalents and Short-Term Investments | 3.19B | 4.18B | 4.11B | 2.65B | 2.61B | 2.70B |
Total Debt | 1.50B | 1.47B | 1.53B | 1.72B | 1.82B | 1.95B |
Total Liabilities | 6.78B | 6.83B | 6.79B | 7.31B | 6.62B | 6.17B |
Stockholders Equity | 14.02B | 14.51B | 13.59B | 12.46B | 11.52B | 11.04B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 616.71M | 1.56B | 463.96M | 458.19M | -276.16M |
Operating Cash Flow | 0.00 | 1.20B | 1.89B | 740.45M | 1.17B | 612.20M |
Investing Cash Flow | 0.00 | -513.24M | -160.28M | -221.82M | -1.13B | -925.44M |
Financing Cash Flow | 0.00 | -419.51M | -458.45M | -287.84M | -332.95M | -204.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥11.64B | 9.13 | 3.08% | 9.24% | 12.50% | ||
76 Outperform | ¥146.64B | 10.71 | 2.56% | 1.36% | 12.13% | ||
75 Outperform | ¥14.14B | 12.29 | 3.65% | 0.73% | 10.12% | ||
73 Outperform | ¥25.13B | 14.48 | 5.30% | -3.07% | -44.51% | ||
69 Neutral | ¥23.08B | 8.12 | 3.77% | 5.63% | 6.00% | ||
62 Neutral | ¥3.17B | 847.84 | 2.93% | -1.64% | -98.70% | ||
44 Neutral | C$930.37M | -8.85 | -0.23% | 2.70% | 23.24% | -42.28% |